BREATH Committees

The Management Board, Steering Committee and the Scientific and Economic Advisory Board are the committees set up at the BREATH site to ensure a successful scientific and economic cooperation.

Management Board

The Management Board was elected on January 12, 2016 from the BREATH faculty for a second term of three years:

Prof. Dr. Gesine Hansen

Prof. Dr. Dr. Axel Haverich

Prof. Dr. Norbert Krug (ITEM)

Prof. Dr. Tobias Welte.

Prof. Dr. Tobias Welte also occupies the position of Site Director for Hannover within the DZL.

Steering Committee

The Steering Committee constitutes the highest decision-making committee in the BREATH research network and is made up of

the Management Board

Prof. Dr. Tobias Welte

Prof. Dr. Gesine Hansen

Prof. Dr. Dr. Axel Haverich

Prof. Dr. Norbert Krug

the Managing Director

Dr. Annegret Zurawski

one member each from the disease areas Asthma und Allergic Diseases (AA) and Endstage Lung Diseases (ELD)

Prof. Dr. Jens Hohlfeld (Fraunhofer ITEM)

Prof. Dr. Ulrich Martin

one representative from the Platforms  

Prof. Dr. Matthias Ochs

one respresentative from the partner LUH

Prof. Dr. J.-Matthias Graf von der Schulenburg

and a patient representative

Michael Wilken.

The above-named members of the Steering Committee were elected on January 12, 2016 in the BREATH General Assembly for a term of three years. Except of Michael Wilken, who is a new member of the committee, it is their second term.

The Steering Committee is responsible for decisions regarding the budget distribution guidelines, the admission of new members into the assembly of doctors and scientists (BREATH Faculty) and the strategic and organizational orientation of the research network. The promotion of young researchers also belongs to the functions of the Steering Committee.

Scientific and Economic Advisory Board

The International Scientific and Economic Advisory Board is currently made up of six members – 

four scientists,

Chairman,

Prof. Dr. Andrew Bush   Professor of Paediatric Respirology, Imperial College & Consultant Paediatric Chest Physician, Royal Brompton & Harefield NHS Foundation Trust

Vice chairman,

Prof. Dr. Peter J. Sterk   Head of Research, Department of Respiratory Diseases, Academic Medical Center, University of Amsterdam

Prof. Dr. Thea Koch   Klinikdirektorin, Klinik und Poliklinik für Anästhesiologie und Intensivtherapie, Universitätsklinikum Carl Gustav Carus an der Technischen Universität Dresden

Prof. Dr. Dirk Van Raemdonck   Head of Clinic, Department of Thoracic Surgery, University Hospitals Leuven

a representative of the pharmaceutical industry,

Prof. Dr. Lothar Färber   Medizinischer Direktor, Novartis Pharma GmbH 

and a representative from a medical insurance company.

Dr. Christoph Vauth   Geschäftsbereichsleiter Versorgungssteuerung, Techniker Krankenkasse, Hamburg

The Advisory Board oversees the scientific and medically innovative progress of BREATH and supports the BREATH Faculty in an advisory capacity. This important function is an honorary position.